Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes

Recent studies suggest that insulin-like growth factor binding protein 2 (IGFBP-2) may protect against type 2 diabetes, but population-based human studies are scarce. We aimed to investigate the prospective association of circulating IGFBP-2 concentrations and of differential methylation in the IGFBP-2 gene with type 2 diabetes risk.

• Publication year

  2018

• Venue

  Diabetes

• Publication date

  2018-11-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2337/db18-0620PMID 30396904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA methylation in the pathogenesis of type 2 diabetes in humans

  2018cited by this paper
• Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes

  2017cited by this paper
• Glucose metabolism and hepatic Igf1 DNA methylation are altered in the offspring of dams fed a low-salt diet during pregnancy.

  2016cited by this paper
• Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice

  2016cited by this paper
• Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.

  2016cited by this paper
• The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth

  2015cited by this paper
• Probe Lasso: A novel method to rope in differentially methylated regions with 450K DNA methylation data

  2015influential reference
• The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness

  2015cited by this paper
• ENCODE data at the ENCODE portal

  2015cited by this paper
• Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study.

  2015cited by this paper
• Analysis pipelines and packages for Infinium HumanMethylation450 BeadChip (450k) data

  2015cited by this paper
• IGFBP-2: The dark horse in metabolism and cancer.

  2015cited by this paper
• Epigenetic dysregulation of the IGF system in placenta of newborns exposed to maternal impaired glucose tolerance.

  2014cited by this paper
• DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.

  2013cited by this paper
• Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men

  2013cited by this paper
• Expression patterns of insulin-like growth factor system members and their correlations with growth and carcass traits in Landrace and Lantang pigs during postnatal development

  2013cited by this paper
• Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women

  2012influential reference
• Functions of DNA methylation: islands, start sites, gene bodies and beyond

  2012cited by this paper
• DNA methylation arrays as surrogate measures of cell mixture distribution

  2012cited by this paper
• IGFBP-2 at the interface of growth and metabolism--implications for childhood obesity.

  2011cited by this paper
• T2DM: Why Epigenetics?

  2011cited by this paper
• Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men

  2011cited by this paper
• Antidiabetic effects of IGFBP2, a leptin-regulated gene.

  2010influential reference
• IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women

  2010cited by this paper
• Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.

  2008influential reference
• Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men

  2008cited by this paper
• IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance

  2007influential reference
• Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort.

  2006cited by this paper
• Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

  2006cited by this paper
• The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

  2006cited by this paper
• Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.

  2006cited by this paper
• Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.

  2004cited by this paper
• Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes.

  2004cited by this paper
• Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.

  2002cited by this paper
• Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition.

  1999cited by this paper
• Recruitment Procedures of EPIC-Germany

  1999cited by this paper
• EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases

  1999cited by this paper
• Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.

  1997cited by this paper
• Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes

  1996cited by this paper
• Promoter-specific imprinting of the human insulin-like growth factor-II gene

  1994cited by this paper
• More powerful procedures for multiple significance testing.

  1990cited by this paper

• Stratifying high-risk prediabetes clusters using blood-based epigenetic markers

  2026cites this paper
• Diagnostic model and identification of IGFBP2 as an aging-related biomarker and therapeutic target for systemic sclerosis-associated interstitial lung disease through integrated bioinformatics and machine learning approaches.

  2026cites this paper
• Greater Concentrations of IGF Binding Protein-2 after Bariatric Surgery Compared with Diet

  2026cites this paper
• Is Predisposition to T2D Impacted by Polymorphisms in Genes Involved in Insulin Signaling and Cellular Bioenergetics?

  2025cites this paper
• Insulin-like growth factor (IGF) and Insulin-like growth factor binding proteins (IGFBP) as predictors of type 2 diabetes risk in obese adults

  2025cites this paper
• Circulating epigenetic signatures classifying brain insulin resistance in humans.

  2025cites this paper
• Lycium barbarum polysaccharide regulates serum metabolites in type 2 diabetic patients with the metabolomics-based approach of GC-TOF-MS

  2025cites this paper
• Type-2 diabetes epigenetic biomarkers: present status and future directions for global and Indigenous health

  2025cites this paper
• Machine learning reveals connections between preclinical type 2 diabetes subtypes and brain health.

  2025cites this paper
• Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.

  2025cites this paper
• Epigenome-wide mediation analysis identified Cytosine-phosphate-Guanine sites linking environmental factors with diabetes indicators

  2025cites this paper
• Dissecting Genetic and Environmental Determinants of Plasma Molecular Signatures and Their Link to Type 2 Diabetes Risk

  2025cites this paper
• Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes

  2024cites this paper
• The potential of circulating free DNA of methylated IGFBP as a biomarker for type 2 diabetes Mellitus: A Comprehensive review.

  2024cites this paper
• Longitudinal clinical and proteomic diabetes signatures in women with a history of gestational diabetes

  2024cites this paper
• Incretin-based therapy: a new horizon in diabetes management

  2024cites this paper
• Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis

  2024cites this paper
• Multi-omics characterization of type 2 diabetes associated genetic variation

  2024cites this paper
• DNA methylation and type 2 diabetes: a systematic review

  2024cites this paper
• Biomarker signatures associated with ageing free of major chronic diseases: results from a population-based sample of the EPIC-Potsdam cohort.

  2024cites this paper
• Identification of distinct trajectories in preclinical type 2 diabetes and their associations with outcomes

  2024cites this paper
• Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.

  2024cites this paper
• Plasma proteomic profile of abdominal obesity in older adults

  2024cites this paper
• Circulating IGF-1 and IGFBP-2 may be biomarkers for risk stratification in patients with acute coronary syndrome: A prospective cohort study.

  2023cites this paper
• Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes

  2023cites this paper
• Protein Markers of Diabetes Discovered in an African American Cohort.

  2023cites this paper
• Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis

  2023cites this paper
• Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes Mellitus

  2023cites this paper
• The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome

  2023cites this paper
• Signaling Pathways of the Insulin-like Growth Factor Binding Proteins

  2023cites this paper
• Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)

  2023cites this paper
• Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis

  2023cites this paper
• Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study

  2023cites this paper
• IGFBP2 secretion by mammary adipocytes limits breast cancer invasion

  2023cites this paper
• Skeletal Muscle Gene Expression Signatures of Obese High and Low Responders to Endurance Exercise Training

  2023influential citation
• Trends in insulin resistance: insights into mechanisms and therapeutic strategy

  2022cites this paper
• A knowledge graph to interpret clinical proteomics data

  2022cites this paper
• Serum plays an important role in reprogramming the seasonal transcriptional profile of brown bear adipocytes

  2022cites this paper
• Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women

  2022cites this paper
• Low IGF-1 and high IGFBP-1 predict diabetes onset in prediabetic patients.

  2022cites this paper
• Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance

  2021cites this paper
• Metabolic syndrome and the plasma proteome: from association to causation

  2021cites this paper
• Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

  2021influential citation
• Analysis of key genes and pathways associated with the pathogenesis of Type 2 diabetes mellitus

  2021cites this paper
• Increased concentrations of myeloperoxidase in serum and serum extracellular vesicles are associated with type 2 diabetes mellitus.

  2021cites this paper
• IGFBP2 protects against pulmonary fibrosis through inhibiting P21-mediated senescence

  2021cites this paper
• Proteome-wide assessment of diabetes mellitus in Qatari identifies IGFBP-2 as a risk factor already with early glycaemic disturbances.

  2020cites this paper
• Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men

  2020influential citation
• Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations.

  2020cites this paper
• A Novel Method of Immunomodulation of Endothelial cells Using Streptococcus Pyogenes and its Lysate

  2020cites this paper
• Clinical Knowledge Graph Integrates Proteomics Data into Clinical Decision-Making

  2020cites this paper
• Epigenetic Changes in Islets of Langerhans Preceding the Onset of Diabetes

  2020cites this paper
• Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression

  2020cites this paper
• Epigenetic contribution to obesity

  2020cites this paper
• Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model

  2020cites this paper
• Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study

  2020cites this paper
• A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population

  2020cites this paper
• The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases

  2020cites this paper
• Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

  2020cites this paper
• Genetic and epigenetic factors determining NAFLD risk

  2020cites this paper
• Epigenetic regulation of insulin action and secretion – role in the pathogenesis of type 2 diabetes

  2020cites this paper
• Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study

  2020influential citation
• Niedriger IGFBP-2-Spiegel deutet auf erhöhtes Diabetesrisiko hin

  2019cites this paper
• 10 Jahre DZD

  2019cites this paper
• Circulating IGFBP‐2: a novel biomarker for incident dementia

  2019cites this paper
• translationale Diabetesforschung

  2019cites this paper
• Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects.

  2019cites this paper
• The short-term high fat diet-induced increase in %5-methylcytosine expression in peripheral blood T lymphocytes, is attenuated by low-dose aspirin

  2019cites this paper
• Faecal virome transplantation decrease symptoms of type-2-diabetes and obesity in a murine model

  2019cites this paper
• Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases

  2019cites this paper